Surgery for hypertrophic obstructive cardiomyopathy: the European perspective
No Thumbnail Available
Authors
Quintana, Eduard
Danchenko, Polina
Rudenko, Kostiantyn
Cicek, Sertaç
Shipolini, Alex
Braun, Jerry
Baufreton, Christophe
Myers, Patrick O.
Färber, Gloria
Dumfarth, Julia
Contact
Check for full-text access
Issue Date
2026
Type
Article
Language
Keywords
Alternative Title
Abstract
Europe has played a foundational role in understanding hypertrophic cardiomyopathy (HCM), yet surgical treatment-particularly septal myectomy-has seen uneven adoption across the continent. Widespread reliance on alcohol septal ablation (ASA) and the more recent introduction of cardiac myosin inhibitors (CMIs) have contributed to a decline in surgical expertise. This perspective reviews the historical evolution of HCM surgery in Europe and the impact of contemporary figures and centers. Drawing on direct correspondence with active European surgeons and institutional data, the manuscript outlines the status of myectomy programs, revealing wide disparities in access, volume, and national coordination. With the data attained here, only three European centers perform more than 25 septal myectomies per year. It also evaluates the clinical and economic implications of surgical versus pharmacological approaches. Emphasis is placed on the urgent need for structured training, procedural standardization, and broader recognition of myectomy as a definitive and cost-effective treatment for obstructive HCM.
Description
Citation
Publisher
License
Journal
Indian journal of thoracic and cardiovascular surgery
Volume
42
Issue
2